Profile | GDS5420 / 224633_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 156.59 | 48 |
GSM1296119 | B_lesional_pre-dose | 203.99 | 52 |
GSM1296076 | C_lesional_pre-dose | ||
GSM1296092 | D_lesional_pre-dose | 212.14 | 55 |
GSM1296103 | E_lesional_pre-dose | 344.56 | 61 |
GSM1296078 | F_lesional_pre-dose | 6.13 | 6 |
GSM1296107 | G_lesional_pre-dose | 198.61 | 52 |
GSM1296109 | H_lesional_pre-dose | 244.68 | 55 |
GSM1296080 | I_lesional_pre-dose | 113.98 | 45 |
GSM1296090 | J_lesional_pre-dose | 239.97 | 56 |
GSM1296074 | K_lesional_pre-dose | 152 | 50 |
GSM1296111 | L_lesional_pre-dose | 157.46 | 47 |
GSM1296099 | M_lesional_pre-dose | 274.54 | 57 |
GSM1296086 | O_lesional_pre-dose | 376.5 | 64 |
GSM1296117 | P_lesional_pre-dose | 62.79 | 31 |
GSM1296113 | Q_lesional_pre-dose | 75.05 | 33 |
GSM1296096 | R_lesional_pre-dose | 320.87 | 60 |
GSM1296105 | S_lesional_pre-dose | 150.48 | 47 |
GSM1296098 | T_lesional_pre-dose | 165.97 | 49 |
GSM1296101 | U_lesional_pre-dose | 226.89 | 54 |
GSM1296121 | V_lesional_pre-dose | 157.34 | 48 |
GSM1296088 | W_lesional_pre-dose | 246.45 | 56 |
GSM1296082 | X_lesional_pre-dose | 351.73 | 63 |
GSM1296115 | Y_lesional_pre-dose | 237.82 | 55 |
GSM1296084 | Z_lesional_pre-dose | 213.18 | 54 |
GSM1296072 | B_lesional_day8 | 169.92 | 49 |
GSM1296069 | L_lesional_day8 | ||
GSM1296071 | P_lesional_day8 | 56.39 | 29 |
GSM1296070 | Y_lesional_day8 | 113.21 | 41 |
GSM1296073 | V_lesional_day8 | 25.13 | 19 |
GSM1296034 | A_lesional_day15 | 100.51 | 40 |
GSM1296041 | G_lesional_day15 | 233.91 | 55 |
GSM1296035 | R_lesional_day15 | 234.01 | 55 |
GSM1296038 | U_lesional_day15 | 216.97 | 54 |
GSM1296047 | B_lesional_day15 | 120.57 | 42 |
GSM1296039 | E_lesional_day15 | 222.05 | 54 |
GSM1296042 | H_lesional_day15 | 78.93 | 35 |
GSM1296043 | L_lesional_day15 | 101.1 | 39 |
GSM1296037 | M_lesional_day15 | 206.69 | 52 |
GSM1296046 | P_lesional_day15 | 31.36 | 20 |
GSM1296044 | Q_lesional_day15 | 68.96 | 33 |
GSM1296045 | Y_lesional_day15 | 76.58 | 34 |
GSM1296025 | C_lesional_day15 | 45.77 | 30 |
GSM1296033 | D_lesional_day15 | 164.34 | 49 |
GSM1296027 | I_lesional_day15 | 151.2 | 50 |
GSM1296032 | J_lesional_day15 | 216.83 | 53 |
GSM1296024 | K_lesional_day15 | 28.45 | 24 |
GSM1296031 | W_lesional_day15 | 214.17 | 53 |
GSM1296028 | X_lesional_day15 | 174.95 | 50 |
GSM1296029 | Z_lesional_day15 | 157.24 | 49 |
GSM1296026 | F_lesional_day15 | 34.96 | 25 |
GSM1296030 | O_lesional_day15 | 160.5 | 51 |
GSM1296040 | S_lesional_day15 | 272.37 | 57 |
GSM1296036 | T_lesional_day15 | 104.25 | 41 |
GSM1296048 | V_lesional_day15 | 89.36 | 38 |
GSM1296059 | A_lesional_day43 | 403.68 | 64 |
GSM1296066 | G_lesional_day43 | 107.89 | 40 |
GSM1296060 | R_lesional_day43 | 274.58 | 57 |
GSM1296063 | U_lesional_day43 | 186.43 | 51 |
GSM1296064 | E_lesional_day43 | 333.62 | 61 |
GSM1296067 | H_lesional_day43 | 144.42 | 45 |
GSM1296062 | M_lesional_day43 | 230.5 | 54 |
GSM1296068 | Q_lesional_day43 | 130.28 | 42 |
GSM1296050 | C_lesional_day43 | 116.52 | 44 |
GSM1296057 | D_lesional_day43 | 411.63 | 64 |
GSM1296052 | I_lesional_day43 | 148.56 | 49 |
GSM1296054 | J_lesional_day43 | 136.88 | 46 |
GSM1296049 | K_lesional_day43 | 70.01 | 36 |
GSM1296055 | W_lesional_day43 | 315.74 | 59 |
GSM1296053 | X_lesional_day43 | 112.21 | 43 |
GSM1296058 | Z_lesional_day43 | 301.66 | 59 |
GSM1296051 | F_lesional_day43 | 91.75 | 41 |
GSM1296056 | O_lesional_day43 | 420.96 | 65 |
GSM1296065 | S_lesional_day43 | 170.39 | 49 |
GSM1296061 | T_lesional_day43 | 75.8 | 36 |
GSM1296095 | A_non-lesional_pre-dose | 83.79 | 39 |
GSM1296120 | B_non-lesional_pre-dose | 167.87 | 48 |
GSM1296077 | C_non-lesional_pre-dose | 21.71 | 19 |
GSM1296093 | D_non-lesional_pre-dose | 152.12 | 47 |
GSM1296104 | E_non-lesional_pre-dose | 186.83 | 51 |
GSM1296079 | F_non-lesional_pre-dose | 89.17 | 40 |
GSM1296108 | G_non-lesional_pre-dose | 183.21 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 92.51 | 37 |
GSM1296081 | I_non-lesional_pre-dose | 197.39 | 53 |
GSM1296091 | J_non-lesional_pre-dose | 214.48 | 54 |
GSM1296075 | K_non-lesional_pre-dose | 58.63 | 34 |
GSM1296112 | L_non-lesional_pre-dose | 102.32 | 38 |
GSM1296100 | M_non-lesional_pre-dose | 332.03 | 60 |
GSM1296087 | O_non-lesional_pre-dose | 192.54 | 54 |
GSM1296118 | P_non-lesional_pre-dose | 141.06 | 44 |
GSM1296114 | Q_non-lesional_pre-dose | 42.93 | 25 |
GSM1296097 | R_non-lesional_pre-dose | 128.72 | 45 |
GSM1296106 | S_non-lesional_pre-dose | 163.54 | 48 |
GSM1296102 | U_non-lesional_pre-dose | 221.27 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 180.99 | 49 |
GSM1296089 | W_non-lesional_pre-dose | 269.14 | 57 |
GSM1296083 | X_non-lesional_pre-dose | 187.28 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 47.82 | 26 |
GSM1296085 | Z_non-lesional_pre-dose | 187.51 | 51 |